Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Stanford University
This is a treatment development trial. Participants will be randomized to receive either XR-enhanced behavioral activation or traditional behavioral activation. All groups will follow a brief-BA protocol developed for primary care settings over a four-session, three-week treatment period.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patient must meet DSM V criteria for MDD
Patient must be at least 18 years of age
Patient must be English speaking
You may not be if
Substance Use Disorders in past year
Any psychosis or bipolar disorder
Any seizure in the last 6 months or untreated epilepsy
Current nonsuicidal self-injury or parasuicidal behavior
Current suicidal urges and intent
Changing psychotherapy treatment within four months of study entry
Changing psychotropic medication(s) within two months of study entry
Clareo Health | Extended Reality Behavioral Activation: An Intervention for Major Depressive Disorder
